期刊文献+

静脉丙种球蛋白在新生儿ABO溶血病中的疗效观察 被引量:7

Curative effect of intravenous immunoglobin on ABO hemolytic disease of the newborn
在线阅读 下载PDF
导出
摘要 目的探讨大剂量丙种球蛋白(intravenous immunoglobu lin,IVIG)在新生儿溶血病(ABO血型不合)中的疗效观察。方法回顾性分析确诊新生儿ABO溶血病120例,A组(23例)为未给予IVIG治疗;B组(33例)在出生24 h内给予IVIG,C组(29例)在生后24~48 h内给予IVIG,D组(35例)在生后48 h后给予IVIG。IVIG剂量均为1 g.kg-1,其余治疗无差别。观察治疗前和治疗后24 h血中胆红素值、血红蛋白,以及各组的总的光疗时间和住院时间。结果血红蛋白差值、血清胆红素的差值、住院时间及蓝光治疗时间:A组和B、C、D组相比均有显著差异(P〈0.01);B组和C、D组间也也有显著性差异(P〈0.01)。C组和D组相比,血胆红素差值有统计学意义(P〈0.05);血红蛋白差值、光疗时间和住院天数差异无显著性(P〉0.05)。A组中有3例需要换血治疗,B、C、D组中均无需换血者(P〈0.01)。结论大剂量丙球治疗新生儿溶血病能迅速减低血清胆红素值,纠正贫血,减少光疗时间和住院时间;且越早给予(生后24 h内),疗效越显著。 Aim To explore the curative effect of intravenous immunoglobin(IVIG)used at different time on ABO hemolytic disease of the newborn.Methods 120 cases of neonatal ABO hemolytic in our hospital were divided into two groups,control group(n=23)and therapy group(n=97).According to different time using IVIG,when therapy group was further divided into three sub groups,Ⅰgroup not exceeding 24 hours after born,Ⅱgroup between 24 hours and 48 hours,Ⅲ group over 48 hours(not exceeding 96 hours).Common clinical data(gestational age,sex,birth weight,blood type constituent ratio,et al),the level of serum bilirubin and hemoglobin,and time of phototherapy and hospital days were analyzed.Results There were no significant differencesin gestational age,sex,birth weight,blood type constituent ratio and other common clinical data(P0.05).But the changes of serum bilirubin and hemoglobin,phototherapy persistence time and hospital days had significant differences in two groups(P0.01).Three cases had exchange transfusion therapy in the end in control group,but nobody in therapy group(P0.01).There were significant differences in changes of serum bilirubin and hemoglobin,phototherapy persistence time and hospital days between Ⅰgroup and Ⅱgroup(P0.01).Changes of serum bilirubin between Ⅱgroup and Ⅲgroup have differences(P0.05),but there were no significant differences in the change of hemoglobin,phototherapy persistence time and hospital days.Conclusion IVIG can quickly reduce serum billirubin,phototherapy persistence time and hospital days,and at the same time control the degree of anaemia.And intravenous IVIG used within 24 hours after birth can have well curative effect.
作者 王珅 潘家华
出处 《安徽医药》 CAS 2011年第4期488-490,共3页 Anhui Medical and Pharmaceutical Journal
关键词 新生儿ABO溶血病 丙球 治疗 ABO hemolytic disease of the newborn immunoglobin therapy
  • 相关文献

参考文献10

  • 1袁学敏,魏胜男,田方.ABO新生儿溶血病的血清学检查[J].检验医学与临床,2008,5(17):1050-1050. 被引量:8
  • 2American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J].Pediatrics,2004,114:297-316.
  • 3Ishimura T,Fujisawa M,Higuchi A,et al.Transforming growth factor-betal expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation[J].Clin Transplant,2001,15(3):185-91.
  • 4Alpay F,Sarici SU,Okutan V,et al.High-dose intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice[J].Acta Pediatics,1999,88:216-9.
  • 5Voto L,Sexer H,Ferreiro G,et al.Neonatal administration of high dose intravenous immunoglobulin in rhesus hemolytic disease[J].Perinat Med,1995,23:443-51.
  • 6Paul LC.Chronic allograft,An update[J].Kidney Int,1999,56(3):783-93.
  • 7Kanya M,Srinivas M,Anil N,et al.Intravenous Immunogloblins in Rhesus Hemolytic Disease[J].Indian Pediatr,2003,70(9):697-9.
  • 8Josep F,Jose M.Intravenous Immunoflobulin and Necrotizing Enterocolitis in Newborn With Hemolytic Disease[J].Pediatrics,2010,125:139-44.
  • 9林志波.早期大剂量丙种球蛋白结合蓝光照射治疗新生儿ABO溶血性黄疸[J].海南医学院学报,2009,15(3):272-273. 被引量:20
  • 10顾婷婷,方永辉.丙种球蛋白治疗新生儿ABO溶血病的疗效分析[J].实用药物与临床,2008,11(2):88-89. 被引量:7

二级参考文献11

共引文献30

同被引文献54

  • 1黄为民,陈红武,李宁,杨明,焦培艳.新生儿溶血病早期干预治疗的临床研究[J].南方医科大学学报,2006,26(9):1350-1351. 被引量:13
  • 2黄雪波.混合血在新生儿溶血病换血治疗中的应用效果分析[J].中国热带医学,2007,7(6):929-929. 被引量:6
  • 3邓长秀,聂采现,何海兰,王强.非换血治疗新生儿ABO溶血病98例疗效观察[J].西部医学,2007,19(5):875-875. 被引量:1
  • 4《中华儿科杂志》编辑委员会,中华医学会儿科学分会新生儿学组.新生儿黄疸诊疗原则的专家共识[J].中华儿科杂志,2010,48:685-686.
  • 5包晓玲,田爱宁.静脉用丙种球蛋白治疗新生儿ABO血型不合溶血病疗效观察[J].中国美容医学,2012,21(z2):126.
  • 6刘艳娟,郑金环,孟庆祝,等.母婴ABO血型不合所致新生儿溶血病早期诊治的临床体会[J].中国中医药科技,2014(z1):124-125.
  • 7Pei S, Yuan W, Mai H, et al. Efficacy of dynamic indices in predict- ing fluid responsiveness in patients with obstructive jaundice [J].Physiol Meas, 2014, 35(3): 369-382.
  • 8Yaser A, Tooke L, Rhoda N.'Interscapular site for transcutaneous bil- irubin measurement in preterm infants: a better and safer screening site [J]. J Perinatol, 2014, 34(3): 209-212.
  • 9Panahi R, Jafari Z, Sheibanizade A, et al. The relationship betwv the behavioral hearing thresholds and maximum bilirubin levels at birth in children with a history of neonatal hyperbilirubinvmia [J]. Iran J Otorhinolaryngol, 2013, 25(72): 127-134.
  • 10Figueras Aloy J, Rodriguez Miguclez JM, Ifiondo Sanz M, ctal. InWavcnous immunoglobulin and nccrotizing cntcrocolifis in new- bores with hemolytic disease [J]. Pediatrics, 2010, 125(1): 139-144.

引证文献7

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部